Qube Research & Technologies LTD Health Catalyst, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 166,591 shares of HCAT stock, worth $1.47 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
166,591
Previous 80,373
107.27%
Holding current value
$1.47 Million
Previous $605,000
75.87%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding HCAT
# of Institutions
167Shares Held
48.7MCall Options Held
2.51MPut Options Held
1.8K-
Black Rock Inc. New York, NY5.43MShares$48 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.53MShares$40 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN3.96MShares$34.9 Million2.3% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.41MShares$21.3 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA2.38MShares$21 Million0.01% of portfolio
About Health Catalyst, Inc.
- Ticker HCAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 54,723,400
- Market Cap $483M
- Description
- Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...